SKorea approves 'SKYCovione' COVID vaccine from SK Bioscience
SEOUL: Taking a major step toward achieving vaccine sovereignty to fight against the pandemic, South Korea on Wednesday approved the u... | News Track
Source: newstracklive.com
Stay updated with breaking news from Isk Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SEOUL: Taking a major step toward achieving vaccine sovereignty to fight against the pandemic, South Korea on Wednesday approved the u... | News Track
Samsung, SK in race to gain lead in CDMO market
SKYCovione is a self-assembled nanoparticle vaccine candidate targeting the receptor binding domain of the SARS-CoV-2 Spike protein for the parental SARS-Cov-2.
SK bioscience closer to obtaining approval for COVID-19 vaccine
Merck's former China head will return to the Big Pharma to lead international human health operations after a short stint at a Chinese company.